| Literature DB >> 34635910 |
Antonino Spinelli1, Stefanos Bonovas2, Johan Burisch3, Torsten Kucharzik4, Michel Adamina5,6, Vito Annese7, Oliver Bachmann8,9, Dominik Bettenworth10, Maria Chaparro11, Wladyslawa Czuber-Dochan12, Piotr Eder13, Pierre Ellul14, Catarina Fidalgo15, Gionata Fiorino16, Paolo Gionchetti17, Javier P Gisbert11, Hannah Gordon18, Charlotte Hedin19, Stefan Holubar20, Marietta Iacucci21, Konstantinos Karmiris22, Konstantinos Katsanos23, Uri Kopylov24, Peter L Lakatos25,26, Theodore Lytras27, Ivan Lyutakov28, Nurulamin Noor29, Gianluca Pellino30, Daniele Piovani31, Edoardo Savarino32, Francesco Selvaggi33, Bram Verstockt34, Glen Doherty35, Tim Raine29, Yves Panis36.
Abstract
This is the second of a series of two articles reporting the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of adult patients with ulcerative colitis [UC]. The first article is focused on medical management, and the present article addresses medical treatment of acute severe ulcerative colitis [ASUC] and surgical management of medically refractory UC patients, including preoperative optimisation, surgical strategies, and technical issues. The article provides advice for a variety of common clinical and surgical conditions. Together, the articles represent an update of the evidence-based recommendations of the ECCO for UC.Entities:
Keywords: Ulcerative colitis [UC]; inflammatory bowel disease [IBD]; surgery
Mesh：
Year: 2022 PMID： 34635910 DOI： 10.1093/ecco-jcc/jjab177
Source DB: PubMed Journal: J Crohns Colitis ISSN： 1873-9946 Impact factor: 9.071